Fresenius Medical Care Corporation (FMS)vsInnovAge Holding Corp (INNV)
FMS
Fresenius Medical Care Corporation
$22.20
+0.59%
HEALTHCARE · Cap: $11.75B
INNV
InnovAge Holding Corp
$10.92
+2.06%
HEALTHCARE · Cap: $1.49B
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 1863% more annual revenue ($19.43B vs $989.71M). FMS leads profitability with a 4.8% profit margin vs -0.3%. FMS earns a higher WallStSmart Score of 58/100 (C).
FMS
Buy58
out of 100
Grade: C
INNV
Avoid26
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+68.5%
Fair Value
$76.29
Current Price
$22.20
$54.09 discount
Margin of Safety
-19.4%
Fair Value
$6.85
Current Price
$10.92
$4.07 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Growing faster than its price suggests
18.3% revenue growth
Areas to Watch
1.4% revenue growth
Grey zone — moderate risk
ROE of 7.5% — below average capital efficiency
4.8% margin — thin
Smaller company, higher risk/reward
ROE of -9.7% — below average capital efficiency
Earnings declined 87.8%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : FMS
The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.74 suggests the stock is reasonably priced for its growth.
Bull Case : INNV
The strongest argument for INNV centers on Revenue Growth. Revenue growth of 18.3% demonstrates continued momentum.
Bear Case : FMS
The primary concerns for FMS are Revenue Growth, Altman Z-Score, Return on Equity. Thin 4.8% margins leave little buffer for downturns.
Bear Case : INNV
The primary concerns for INNV are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
FMS profiles as a value stock while INNV is a growth play — different risk/reward profiles.
FMS carries more volatility with a beta of 0.83 — expect wider price swings.
INNV is growing revenue faster at 18.3% — sustainability is the question.
FMS generates stronger free cash flow (620M), providing more financial flexibility.
Bottom Line
FMS scores higher overall (58/100 vs 26/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →InnovAge Holding Corp
HEALTHCARE · MEDICAL CARE FACILITIES · USA
InnovAge Holding Corp. The company is headquartered in Denver, Colorado.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?